Nordwand Advisors’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-100
| Closed | -$524 | – | 182 |
|
|
2024
Q1 | $524 | Hold |
100
| – | – | ﹤0.01% | 159 |
|
|
2023
Q4 | $523 | Hold |
100
| – | – | ﹤0.01% | 149 |
|
|
2023
Q3 | $1.58K | Hold |
100
| – | – | ﹤0.01% | 120 |
|
|
2023
Q2 | $1.94K | Hold |
100
| – | – | ﹤0.01% | 114 |
|
|
2023
Q1 | $2.84K | Buy |
+100
| New | +$2.84K | ﹤0.01% | 114 |
|